Cardiac Event
50
2
3
30
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.0%
2 terminated out of 50 trials
93.8%
+7.2% vs benchmark
6%
3 trials in Phase 3/4
10%
3 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (50)
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
Virtual World-Based Cardiac Rehabilitation
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Living Healthy for Moms RCT
Effect of Oxiris® Membrane on Microcirculation Following Cardiac Surgery Under Cardiopulmonary Bypass: a Pilot Prospective Monocentric Study (Oxicard Study).
The Improving ATTENDance to Cardiac Rehabilitation Trial
Mobile Health for Cardiac Rehabilitation (Motivate-CR+)
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
LifeVest Safety and Efficacy in Real Life Settings in France
Correlation Between Cardiac Markers and Severity of COVID-19
Supporting Cardiac Rehabilitation With eNutriCardio
Repaired Tetralogy of Fallot Italian Registry
Hemodynamic Parameters and Cardiac Enzyme Levels in Patients Undergoing General Anesthesia
Influence of Cardiac Implantable Electronic Devices on the Hemostatic System
Emotion Regulation Intervention to Sustain Physical Activity in Rural-dwelling Women and Men After Myocardial Infarction
Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients
Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation
Transversus Thoracis Muscle Plane Block for Sternotomy Pain in Cardiac Surgery
Prevena Incision Management
Preoperative Self-assessment for Cardio-pulmonary Risk Stratification